These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29739880)

  • 1. CCR5 adopts three homodimeric conformations that control cell surface delivery.
    Jin J; Momboisse F; Boncompain G; Koensgen F; Zhou Z; Cordeiro N; Arenzana-Seisdedos F; Perez F; Lagane B; Kellenberger E; Brelot A
    Sci Signal; 2018 May; 11(529):. PubMed ID: 29739880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5).
    Garcia-Perez J; Rueda P; Alcami J; Rognan D; Arenzana-Seisdedos F; Lagane B; Kellenberger E
    J Biol Chem; 2011 Sep; 286(38):33409-21. PubMed ID: 21775441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.
    Zheng Y; Han GW; Abagyan R; Wu B; Stevens RC; Cherezov V; Kufareva I; Handel TM
    Immunity; 2017 Jun; 46(6):1005-1017.e5. PubMed ID: 28636951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status.
    Momboisse F; Nardi G; Colin P; Hery M; Cordeiro N; Blachier S; Schwartz O; Arenzana-Seisdedos F; Sauvonnet N; Olivo-Marin JC; Lagane B; Lagache T; Brelot A
    Elife; 2022 Jul; 11():. PubMed ID: 35866628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational study on the interaction between CCR5 and HIV-1 entry inhibitor maraviroc: insight from accelerated molecular dynamics simulation and free energy calculation.
    Bai Q; Zhang Y; Li X; Chen W; Liu H; Yao X
    Phys Chem Chem Phys; 2014 Nov; 16(44):24332-8. PubMed ID: 25296959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand- and mutation-induced conformational selection in the CCR5 chemokine G protein-coupled receptor.
    Abrol R; Trzaskowski B; Goddard WA; Nesterov A; Olave I; Irons C
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13040-5. PubMed ID: 25157173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct measurement of thermal stability of expressed CCR5 and stabilization by small molecule ligands.
    Knepp AM; Grunbeck A; Banerjee S; Sakmar TP; Huber T
    Biochemistry; 2011 Feb; 50(4):502-11. PubMed ID: 21155586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically encoded photo-cross-linkers map the binding site of an allosteric drug on a G protein-coupled receptor.
    Grunbeck A; Huber T; Abrol R; Trzaskowski B; Goddard WA; Sakmar TP
    ACS Chem Biol; 2012 Jun; 7(6):967-72. PubMed ID: 22455376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular binding mode of PF-232798, a clinical anti-HIV candidate, at chemokine receptor CCR5.
    Zhu Y; Zhao YL; Li J; Liu H; Zhao Q; Wu BL; Yang ZL
    Acta Pharmacol Sin; 2019 Apr; 40(4):563-568. PubMed ID: 29941870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human chemokine receptors CCR5, CCR3 and CCR2B share common polarity motif in the first extracellular loop with other human G-protein coupled receptors implications for HIV-1 coreceptor function.
    Efremov R; Truong MJ; Darcissac EC; Zeng J; Grau O; Vergoten G; Debard C; Capron A; Bahr GM
    Eur J Biochem; 1999 Aug; 263(3):746-56. PubMed ID: 10469138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5 Revisited: How Mechanisms of HIV Entry Govern AIDS Pathogenesis.
    Brelot A; Chakrabarti LA
    J Mol Biol; 2018 Aug; 430(17):2557-2589. PubMed ID: 29932942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor conformation and constitutive activity in CCR5 chemokine receptor function and HIV infection.
    Flanagan CA
    Adv Pharmacol; 2014; 70():215-63. PubMed ID: 24931198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanism Regarding Allosteric Modulation of Ligand Binding and the Impact of Mutations on Dimerization for CCR5 Homodimer.
    Zhang F; Yuan Y; Xiang M; Guo Y; Li M; Liu Y; Pu X
    J Chem Inf Model; 2019 May; 59(5):1965-1976. PubMed ID: 30688454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Mechanism of Action for Allosteric Modulators and Agonists in CC-chemokine Receptor 5 (CCR5).
    Karlshøj S; Amarandi RM; Larsen O; Daugvilaite V; Steen A; Brvar M; Pui A; Frimurer TM; Ulven T; Rosenkilde MM
    J Biol Chem; 2016 Dec; 291(52):26860-26874. PubMed ID: 27834679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Based Design of 1-Heteroaryl-1,3-propanediamine Derivatives as a Novel Series of CC-Chemokine Receptor 5 Antagonists.
    Peng P; Chen H; Zhu Y; Wang Z; Li J; Luo RH; Wang J; Chen L; Yang LM; Jiang H; Xie X; Wu B; Zheng YT; Liu H
    J Med Chem; 2018 Nov; 61(21):9621-9636. PubMed ID: 30234300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs.
    Seibert C; Sakmar TP
    Curr Pharm Des; 2004; 10(17):2041-62. PubMed ID: 15279544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine Levels Induced by Substance Abuse Alter Efficacy of Maraviroc and Expression of CCR5 Conformations on Myeloid Cells: Implications for NeuroHIV.
    Matt SM; Nickoloff-Bybel EA; Rong Y; Runner K; Johnson H; O'Connor MH; Haddad EK; Gaskill PJ
    Front Immunol; 2021; 12():663061. PubMed ID: 34093554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists.
    Kondru R; Zhang J; Ji C; Mirzadegan T; Rotstein D; Sankuratri S; Dioszegi M
    Mol Pharmacol; 2008 Mar; 73(3):789-800. PubMed ID: 18096812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approach.
    Gadhe CG; Kothandan G; Cho SJ
    J Biomol Struct Dyn; 2013; 31(11):1251-76. PubMed ID: 23153179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc.
    Borm K; Jakobsen MR; Cashin K; Flynn JK; Ellenberg P; Ostergaard L; Lee B; Churchill MJ; Roche M; Gorry PR
    Retrovirology; 2016 Nov; 13(1):74. PubMed ID: 27809912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.